Ruxolitinib for refractory large granular lymphocyte leukemia. Moignet A, Pastoret C, Cartron G, Coppo P, et al. Am J Hematol 2021 Jun 16. doi: 10.1002/ajh.26275.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moignet A, Pastoret C, Cartron G, Coppo P, et al. Ruxolitinib for refractory large granular lymphocyte leukemia. Am J Hematol 2021 Jun 16. doi: 10.1002/ajh.26275.
PMID: 34133042